Shenzhen Glory Medical Co.,Ltd. (002551.SZ)
CNY 3.21
(2.56%)
CNY 3.21
(2.56%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 371.54 Million CNY | -10.85% |
| 2022 | 416.78 Million CNY | 10.87% |
| 2021 | 375.9 Million CNY | 9.38% |
| 2020 | 343.65 Million CNY | 13.44% |
| 2019 | 302.94 Million CNY | 19.03% |
| 2018 | 254.5 Million CNY | -29.47% |
| 2017 | 360.85 Million CNY | 10.34% |
| 2016 | 327.02 Million CNY | 9.34% |
| 2015 | 299.08 Million CNY | -10.17% |
| 2014 | 332.94 Million CNY | 13.42% |
| 2013 | 293.54 Million CNY | 346.25% |
| 2012 | 65.77 Million CNY | 57.13% |
| 2011 | 41.86 Million CNY | -33.43% |
| 2010 | 62.88 Million CNY | 97.28% |
| 2009 | 31.87 Million CNY | 13.35% |
| 2008 | 28.12 Million CNY | 61.48% |
| 2007 | 17.41 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 350.15 Million CNY | -3.79% |
| 2024 Q1 | 363.92 Million CNY | -2.05% |
| 2024 Q3 | 332.82 Million CNY | -4.95% |
| 2023 Q3 | 410.67 Million CNY | -0.34% |
| 2023 Q2 | 412.06 Million CNY | 7.11% |
| 2023 Q1 | 384.71 Million CNY | -7.69% |
| 2023 Q4 | 371.54 Million CNY | -9.53% |
| 2023 FY | 371.54 Million CNY | -10.85% |
| 2022 FY | 416.78 Million CNY | 10.87% |
| 2022 Q3 | 381.59 Million CNY | 17.18% |
| 2022 Q4 | 416.78 Million CNY | 9.22% |
| 2022 Q1 | 328.51 Million CNY | -12.61% |
| 2022 Q2 | 325.64 Million CNY | -0.87% |
| 2021 Q4 | 375.9 Million CNY | -25.88% |
| 2021 FY | 375.9 Million CNY | 9.38% |
| 2021 Q1 | 337.82 Million CNY | -1.7% |
| 2021 Q2 | 378.63 Million CNY | 12.08% |
| 2021 Q3 | 507.12 Million CNY | 33.94% |
| 2020 Q4 | 343.65 Million CNY | -30.66% |
| 2020 Q2 | 333.35 Million CNY | 27.87% |
| 2020 Q1 | 260.69 Million CNY | -13.95% |
| 2020 FY | 343.65 Million CNY | 13.44% |
| 2020 Q3 | 495.59 Million CNY | 48.67% |
| 2019 Q3 | 339.39 Million CNY | 16.78% |
| 2019 Q2 | 290.62 Million CNY | 9.66% |
| 2019 FY | 302.94 Million CNY | 19.03% |
| 2019 Q4 | 302.94 Million CNY | -10.74% |
| 2019 Q1 | 265.01 Million CNY | 4.13% |
| 2018 FY | 254.5 Million CNY | -29.47% |
| 2018 Q1 | 374.47 Million CNY | 3.77% |
| 2018 Q2 | 331.93 Million CNY | -11.36% |
| 2018 Q3 | 366.91 Million CNY | 10.54% |
| 2018 Q4 | 254.5 Million CNY | -30.64% |
| 2017 Q1 | 306.21 Million CNY | -6.36% |
| 2017 Q4 | 360.85 Million CNY | 12.87% |
| 2017 Q3 | 319.7 Million CNY | 11.57% |
| 2017 Q2 | 286.55 Million CNY | -6.42% |
| 2017 FY | 360.85 Million CNY | 10.34% |
| 2016 Q2 | 348.99 Million CNY | 4.67% |
| 2016 Q1 | 333.41 Million CNY | 11.48% |
| 2016 FY | 327.02 Million CNY | 9.34% |
| 2016 Q4 | 327.02 Million CNY | -16.2% |
| 2016 Q3 | 390.25 Million CNY | 11.82% |
| 2015 Q1 | 380.26 Million CNY | 14.21% |
| 2015 FY | 299.08 Million CNY | -10.17% |
| 2015 Q4 | 299.08 Million CNY | -21.34% |
| 2015 Q3 | 380.21 Million CNY | 8.35% |
| 2015 Q2 | 350.9 Million CNY | -7.72% |
| 2014 Q1 | 288.41 Million CNY | -1.75% |
| 2014 FY | 332.94 Million CNY | 13.42% |
| 2014 Q4 | 332.94 Million CNY | 10.59% |
| 2014 Q3 | 301.07 Million CNY | 12.12% |
| 2014 Q2 | 268.52 Million CNY | -6.9% |
| 2013 Q4 | 293.54 Million CNY | 366.02% |
| 2013 FY | 293.54 Million CNY | 346.25% |
| 2013 Q2 | 49.13 Million CNY | 28.21% |
| 2013 Q3 | 62.98 Million CNY | 28.21% |
| 2013 Q1 | 38.32 Million CNY | -41.74% |
| 2012 FY | 65.77 Million CNY | 57.13% |
| 2012 Q1 | 31.03 Million CNY | -25.88% |
| 2012 Q2 | 36.37 Million CNY | 17.21% |
| 2012 Q3 | 65.77 Million CNY | 80.84% |
| 2012 Q4 | 65.77 Million CNY | 0.01% |
| 2011 Q2 | 27.44 Million CNY | -44.98% |
| 2011 Q3 | 37.5 Million CNY | 36.68% |
| 2011 FY | 41.86 Million CNY | -33.43% |
| 2011 Q4 | 41.86 Million CNY | 11.61% |
| 2011 Q1 | 49.87 Million CNY | -20.69% |
| 2010 Q2 | 29.23 Million CNY | 0.0% |
| 2010 FY | 62.88 Million CNY | 97.28% |
| 2010 Q4 | 62.88 Million CNY | 0.0% |
| 2009 FY | 31.87 Million CNY | 13.35% |
| 2008 FY | 28.12 Million CNY | 61.48% |
| 2007 FY | 17.41 Million CNY | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| China National Accord Medicines Corporation Ltd. | 7.98 Billion CNY | 95.349% |
| Realcan Pharmaceutical Group Co., Ltd. | 1.11 Billion CNY | 66.799% |